Author:
Bazzichi Laura,Rossi Paolo,Giacomelli Camillo,De Feo Francesca,Bobbio-Pallavicini Francesca,Rossi Alessandra,Baldini Chiara,Consensi Arianna,Doveri Marica,Bonino Claudia,Mazzantini Maurizio,Della Rossa Alessandra,Montecucco Carlomaurizio,Bombardieri Stefano
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference20 articles.
1. Redich K, Schtt G, Steiner G, Hayer S, Wagner EF, Smolen JS (2003) Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. Arthritis Rheum 48:3308–3319
2. Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M (2007) Biological and clinical effects of anti-TNF-alpha treatment. Autoimmun Rev 7:35–41. (Epub 2007 Mar 26)
3. Han C, Smolen J, Kavanaugh A, van der Heijde D, Braun J, Westhovens R, Zhao N, Rahman MU, Baker D, Bala M (2007) The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases. Arthritis Res Ther 9:103
4. Pavelka K, Gatterová J, Tegzová D, Jarosová K, Tomasová Studýnková J, Svobodník A, Svihálek J, Dusek L, Vencovský J (2007) Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment. Clin Exp Rheumatol 25:540–545
5. Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J (2006) Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:529–533
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献